A PSO-fused model combining text, speech and video representations reached 94.0% accuracy on 690 labeled television-dialogue utterances in the MUStARD benchmark.
A particle swarm optimization strategy that dynamically selects the most informative clients in federated learning matches ...
PASI 100 and 86% PASI 90 in the ORKA-001 high-dose (600 mg) group, highly similar to EVERLAST-AContinued favorable safety and tolerability ...
European Commission approves Novartis’ Cosentyx to treat adults with polymyalgia rheumatica: Basel Friday, October 23, 2026, 16:00 Hrs [IST] Novartis announced that the European ...
Oruka Therapeutics, Inc. announced positive Week 16 results from its EVERLAST-B Phase 2b trial of ORKA-001, a novel half-life extended IL-23p19 monoclonal antibody, in moderate-to-severe PsO. EVERLAST ...
Cosentyx (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR,1 a common inflammatory rheumatic disease with limited advanced treatment options2-6Approval based ...
Corporation commissioners discussed a possible resolution that would result in a bill increase for all PSO customer classes ...
Online banks have grown in popularity thanks to lower fees, better rates and the convenience of being able to bank from anywhere (especially advantageous for busy business owners on the go). Below, ...
Republicans eliminated Tennessee’s only Black-majority district, so Justin J. Pearson took a campaign about economic ...
Cosentyx® (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR,1 a common ...
(PRESS RELEASE) IMMINGHAM, England, United Kingdom, 22-Oct-2026 — / EuropaWire / — Associated British Ports (ABP) has appointed two senior managers to strengthen its unitised operations at the ports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results